Armata Pharmaceuticals In... (ARMP)
AMEX: ARMP
· Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT
Armata Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.21M | -8.77M | -6.05M | -5.42M | -6.19M | -5.5M |
Depreciation & Amortization | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 228K | 230K | 245K | 226K | 195K | 226K | 277K | 314K | 297K | 281K |
Stock-Based Compensation | 575K | 781K | 354K | 670K | 1.33M | 534K | 193K | -373K | 261K | 857K | 817K | 846K | 949K | 493K | 664K | 469K | 907K | 842K |
Other Working Capital | -1.73M | -644K | 2.91M | -1.05M | -7K | -204K | 197K | 529K | -4.42M | -5.99M | -4.9M | -2.79M | -77K | 3.6M | -3.68M | 396K | 452K | -170K |
Other Non-Cash Items | 10.14M | -1.01M | -12.45M | -3.43M | -20.15M | 15.28M | 11.12M | 17.67M | -6.04M | 3.16M | 439K | 2.32M | 1.3M | n/a | -3.22M | -2K | n/a | 62K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -419K | 3.86M | n/a | n/a | -439K | -2.32M | -1.3M | n/a | 3.22M | -722K | n/a | -586K |
Change in Working Capital | -2M | -1.2M | 1.19M | -935K | -661K | -1.69M | 557K | 92K | -2.97M | -7.33M | -1.23M | -2.79M | -77K | 4.54M | -3.49M | 396K | 452K | -579K |
Operating Cash Flow | -7.21M | -7.58M | -7.93M | -8.86M | -10.18M | -10.58M | -8.11M | -9.69M | -12.06M | -17.57M | -10.48M | -10.33M | -8.15M | -3.52M | -8.6M | -4.96M | -4.54M | -5.47M |
Capital Expenditures | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.4M | -3.51M | -222K | -2.01M | 455K | -1.29M | -1.14M | -236K | -228K | -582K | -196K | -298K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -149K | -99K | 77K | -340K | -1.37M | -250K | -2.39M | -3.51M | -222K | -2.01M | 455K | -1.29M | -1.14M | -236K | -228K | -582K | -196K | -298K |
Debt Repayment | n/a | 10M | -34.89M | n/a | n/a | 34.89M | n/a | 24.8M | -368K | 29.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -14K | n/a | n/a | n/a | n/a | -43K | n/a | n/a | n/a | n/a | n/a | -146K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 34.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | 31K | n/a | n/a | 82K | 86K | n/a | -969K |
Financial Cash Flow | n/a | 9.99M | n/a | -61K | 88K | 34.93M | -43K | 24.8M | -368K | 29.59M | -500K | 31K | -146K | 44.63M | 7.04M | 86K | -185K | 18.58M |
Net Cash Flow | -7.36M | 2.31M | -7.85M | -9.26M | -11.46M | 24.1M | -10.44M | 11.61M | -12.65M | 10.01M | -10.53M | -11.6M | -9.43M | 40.88M | -1.79M | -5.46M | -4.92M | 12.81M |
Free Cash Flow | -7.36M | -7.68M | -7.85M | -9.2M | -11.54M | -10.83M | -10.51M | -13.2M | -12.28M | -19.58M | -10.03M | -11.63M | -9.28M | -3.75M | -8.83M | -5.55M | -4.73M | -5.77M |